GALLANT 5 Tesaglitazar Versus Metformin

Clinical trial NCT00214591 · TERMINATED

Trial details

NCT number: NCT00214591
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2004-08-01
Primary completion: 2006-12-01
Enrollment: 580

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.